In factor analysis, we identified six uncorrelated factors among the studied clinical chemistry biomarkers, among which the composite ‘LDL profile’ and ‘albumin & CRP’ factors were associated with a decreased risk of mortality after ALS diagnosis. This evidence concerns the gene ALB and amyotrophic lateral sclerosis.